Return to CG120 Overview

Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings [CG120]

Measuring the use of this guidance

Recommendation: 1.2.1

Healthcare professionals in all settings, including primary care, secondary care mental health services, CAMHS and accident and emergency departments, and those in prisons and criminal justice mental health liaison schemes, should routinely ask adults and young people with known or suspected psychosis about their use of alcohol and/or prescribed and non-prescribed (including illicit) drugs. If the person has used substances ask them about all of the following: particular substance(s) used - quantity, frequency and pattern of use - route of administration - duration of current level of use. In addition, conduct an assessment of dependency (see Drug misuse: opioid detoxification [NICE clinical guideline 52] and Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence [NICE clinical guideline 115]) and also seek corroborative evidence from families, carers or significant others, where this is possible and permission is given.

What was measured: Proportion of adults in the community, with a diagnosis of schizophrenia or schizo-affective disorder, who had their alcohol consumption recorded at least once in the previous 12 months.
Data collection end: November 2017
87%
Area covered: England and Wales
Source: Royal College of Psychiatrists. National Clinical Audit of Psychosis.

What was measured: Proportion of adults in the community, with a diagnosis of schizophrenia or schizo-affective disorder, who had a record of substance misuse monitoring at least once in the previous 12 months.
Data collection end: November 2017
86%
Area covered: England and Wales
Source: Royal College of Psychiatrists. National Clinical Audit of Psychosis.



 Return to CG120 Overview